Open AccessClinical Feature and Survival Outcomes of Lung Cancer with ALK Mutation Positive and Treated with Crizotinib, Single Centre Experience
Author(s) -
Burak Bi̇lgi̇n,
Şebnem Yücel
Publication year - 2019
Publication title -
acta oncologica turcica
Language(s) - English
Resource type - Journals
ISSN - 0304-596X
DOI - 10.5505/aot.2019.52523
Subject(s) - crizotinib , lung cancer , oncology , medicine , feature (linguistics) , mutation , biology , genetics , gene , linguistics , philosophy , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom